The vaccine against covid-19 is expected to arrive in Latin America in March or April 2021, after being distributed to the United States and Europe, according to the pharmaceutical group that will produce the Oxford vaccine.
So far, none of the 175 vaccines that are being developed in the world have been approved for commercialization.
However, the approval of some of the vaccines should occur soon, later this month or next, if unforeseen does not arise, recalled Hugo Sigman, founder and general director of the pharmaceutical group Insud, which will produce the vaccine developed by the University of Oxford and from AstraZeneca.
The statements by pharmacist Hugo Sigman were made today during the online seminar organized by the Organization of Ibero-American States (OEI) and are being quoted by the Spanish news agency EFE.
According to the pharmacist, it is not yet possible to know how long the antibodies of a vaccinated person will last, but it is expected to be at least one year, similarly to what happens with the flu vaccine.
